Key facts
- This page summarizes Christopher M. Smith's Form 4 filing for NEOGENOMICS INC (NEO).
- 3 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 15 May 2023, 17:07.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Award
No transaction description listed
Additional SEC filing notes
Footnote F1
On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F2
On May 11, 2023, Mr. Smith was granted 269,841 stock options. These options vest ratably over the first three anniversary dates of the grant date.
Footnote F3
On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
Footnote F4
Once vested, the shares of common stock are not subject to expiration.
Footnote F5
On May 11, 2023, Mr. Smith was granted 144,190 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 216,285. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.